4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-14-018066
CIK 0001516479operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:03 PM ET
Size
32.0 KB
Accession
0001209191-14-018066
Insider Transaction Report
Form 4
Dillaha Larry
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2014-03-05$10.89/sh+18,750$204,188→ 21,875 total - Exercise/Conversion
Common Stock
2014-03-05$3.54/sh+19,056$67,458→ 40,931 total - Sale
Common Stock
2014-03-05$72.65/sh−97,789$7,104,371→ 55,268 total - Sale
Common Stock
2014-03-05$83.92/sh−653$54,800→ 54,078 total - Sale
Common Stock
2014-03-05$81.91/sh−4,680$383,339→ 48,774 total - Sale
Common Stock
2014-03-05$79.81/sh−3,811$304,156→ 39,246 total - Sale
Common Stock
2014-03-05$78.59/sh−2,304$181,071→ 36,942 total - Sale
Common Stock
2014-03-05$76.25/sh−15,954$1,216,493→ 3,125 total - Disposition to Issuer
Stock Option (right to buy)
2014-03-05−19,056→ 29,944 totalExercise: $3.54Exp: 2022-12-26→ Common Stock (19,056 underlying) - Sale
Common Stock
2014-03-05$82.55/sh−624$51,511→ 53,454 total - Sale
Common Stock
2014-03-05$77.24/sh−17,863$1,379,738→ 19,079 total - Disposition to Issuer
Stock Option (right to buy)
2014-03-05−18,750→ 81,250 totalExercise: $10.89Exp: 2023-05-13→ Common Stock (18,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-03-05−112,126→ 0 totalExercise: $1.83Exp: 2020-04-04→ Common Stock (112,126 underlying) - Exercise/Conversion
Common Stock
2014-03-05$1.83/sh+112,126$205,191→ 153,057 total - Sale
Common Stock
2014-03-05$84.72/sh−537$45,495→ 54,731 total - Sale
Common Stock
2014-03-05$80.25/sh−5,717$458,789→ 43,057 total
Footnotes (13)
- [F1]Includes 3,125 shares acquired by the Reporting Person on December 11, 2013 pursuant to the Issuer's Employer Stock Purchase Plan.
- [F10]The weighted average sales price for the transaction reported was $76.25, and the range of prices were between $75.90 and $76.90.
- [F11]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.
- [F12]The option vests in 36 equal monthly installments and will be fully vested and exercisable on December 27, 2015.
- [F13]The option is fully vested and exercisable.
- [F2]The weighted average sales price for the transaction reported was $84.72, and the range of prices were between $84.40 and $85.00.
- [F3]The weighted average sales price for the transaction reported was $83.92, and the range of prices were between $83.38 and $84.27.
- [F4]The weighted average sales price for the transaction reported was $82.55, and the range of prices were between $82.14 and $83.00.
- [F5]The weighted average sales price for the transaction reported was $81.91, and the range of prices were between $81.12 and $82.12.
- [F6]The weighted average sales price for the transaction reported was $80.25, and the range of prices were between $80.09 and $80.93.
- [F7]The weighted average sales price for the transaction reported was $79.81, and the range of prices were between $79.08 and $80.08.
- [F8]The weighted average sales price for the transaction reported was $78.59, and the range of prices were between $78.00 and $79.00.
- [F9]The weighted average sales price for the transaction reported was $77.24, and the range of prices were between $76.92 and $77.84.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:03 PM ET
- Size
- 32.0 KB